Related Experiment Video
Updated: Oct 29, 2025
09:23
Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
2.2K
A commentary on the development of engineered phage as therapeutics
Anne M L Barnard1, Heather I M Fairhead1
1Phico Therapeutics Ltd, Bertarelli Building, Bourn Hall, High Street, Bourn CB23 2TN, UK.
Drug Discovery Today
|July 8, 2021
Summary
Engineered phages show promise for improving phage therapy against bacterial infections. Further research into phage engineering is crucial for developing novel therapeutics.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Bacterial infections pose a significant global health threat.
- Phage therapy, using bacteriophages to kill bacteria, is a promising alternative to antibiotics.
- Wild-type (WT) phages have limitations for therapeutic use.
Purpose of the Study:
- To explore the potential of engineered phages in overcoming challenges in phage therapy.
- To identify key research areas for advancing novel phage therapeutics.
Main Methods:
- Review of current research in phage engineering techniques.
- Analysis of technical challenges associated with phage therapy.
- Identification of future research directions.
Main Results:
- Phage engineering can enhance the efficacy and safety of phage-based treatments.
- Specific engineering strategies can address limitations such as narrow host range and bacterial resistance.
- Targeted research is needed to optimize phage design and delivery.
Conclusions:
- Engineered phages represent a significant advancement in combating bacterial infections.
- Continued research and development in phage engineering are essential for realizing the full potential of phage therapy.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
73.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
73.6K
01:26DNA Bacteriophages
323
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
323
01:29Microorganisms in Medicine and Therapeutics
544
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
544
00:43Lysogenic Cycle of Bacteriophages
64.6K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
64.6K
01:16Viral Replication: Lysogenic Cycle
548
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
548
01:20Viral Replication: Lytic Cycle
574
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
574